Rong-Sheng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rong-Sheng Zhao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ai-Hua Zhang
Department of Nephrology, Xuanwu Hospital, Capital Medical University
1 shared publication Dan-Dan Li
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University BeijingPeople’s Republic of China; Department of Pharmacy, Peking University Third Hospital BeijingPeople’s Republic of China
1 shared publicationHong-Gang Nie
Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Institute of Analytical Chemistry, College of Chemistry and Molecular Engineering, Peking University BeijingPeople’s Republic of China
1 shared publicationMin-Hua Fan
Department of Nephrology, Peking University Third Hospital BeijingPeople’s Republic of China
1 shared publicationQiong Bai
Department of Nephrology, Peking University Third Hospital BeijingPeople’s Republic of China
1 shared publicationSong Wang
Department of Nephrology, Peking University Third Hospital BeijingPeople’s Republic of China
1 shared publication
Latest Publications
- 11 September 2013
- Published by Taylor & Francis in Biomarkers
- Vol. 18 (7) , 601-606
Changes of urinary phospholipids in the chronic kidney disease patients
Objective: To evaluate whether urinary phospholipids could be regarded as biomarkers of chronic kidney disease. Materials and methods: Thirteen healthy volunteers and 26 consecutive chronic kidney disease patients were included. Urinary phospholipids were quantified by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Results: Urinary phosphatidylcholines concentrations (PC 16:0/16:0, 16:0/22:3, 16:0/18:1 and 16:0/18:2) were significantly higher both in glomerulonephritis group (all p < 0.001) and in tubulointerstitial injury group (all p < 0.05) than in healthy control group. Meanwhile, sphingomyelin concentrations (SM 18:1/16:0 and 18:1/18:0) in glomerulonephritis group were significantly higher than those in healthy control group (all p < 0.001). Urinary PCs and SMs were positively correlated with proteinuria but negatively correlated with serum albumin. Meanwhile, PCs were positively correlated with serum creatinine. Conclusion: Our work first demonstrated that urinary phospholipids might be biomarkers for the chronic kidney disease patients. Increased urinary phospholipids in chronic kidney disease patients might result from proteinuria, damaged kidney function or proteinuria induced hypoalbuminemia or lipotoxicity.
- 11 September 2013
- Published by Taylor & Francis in Biomarkers
- Vol. 18 (7) , 601-606
Changes of urinary phospholipids in the chronic kidney disease patients
Objective: To evaluate whether urinary phospholipids could be regarded as biomarkers of chronic kidney disease. Materials and methods: Thirteen healthy volunteers and 26 consecutive chronic kidney disease patients were included. Urinary phospholipids were quantified by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Results: Urinary phosphatidylcholines concentrations (PC 16:0/16:0, 16:0/22:3, 16:0/18:1 and 16:0/18:2) were significantly higher both in glomerulonephritis group (all p < 0.001) and in tubulointerstitial injury group (all p < 0.05) than in healthy control group. Meanwhile, sphingomyelin concentrations (SM 18:1/16:0 and 18:1/18:0) in glomerulonephritis group were significantly higher than those in healthy control group (all p < 0.001). Urinary PCs and SMs were positively correlated with proteinuria but negatively correlated with serum albumin. Meanwhile, PCs were positively correlated with serum creatinine. Conclusion: Our work first demonstrated that urinary phospholipids might be biomarkers for the chronic kidney disease patients. Increased urinary phospholipids in chronic kidney disease patients might result from proteinuria, damaged kidney function or proteinuria induced hypoalbuminemia or lipotoxicity.